Aigen Investment Management LP Makes New $333,000 Investment in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Aigen Investment Management LP purchased a new position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) in the third quarter, according to its most recent filing with the SEC. The firm purchased 5,012 shares of the company’s stock, valued at approximately $333,000.

A number of other large investors have also recently bought and sold shares of RYAN. Janney Montgomery Scott LLC grew its holdings in Ryan Specialty by 57.3% during the 1st quarter. Janney Montgomery Scott LLC now owns 12,136 shares of the company’s stock worth $674,000 after acquiring an additional 4,421 shares during the period. Swiss National Bank boosted its position in shares of Ryan Specialty by 1.7% during the 1st quarter. Swiss National Bank now owns 198,400 shares of the company’s stock worth $11,011,000 after purchasing an additional 3,300 shares in the last quarter. Nicolet Advisory Services LLC bought a new position in shares of Ryan Specialty during the 1st quarter worth about $412,000. Champlain Investment Partners LLC boosted its position in shares of Ryan Specialty by 28.0% during the 1st quarter. Champlain Investment Partners LLC now owns 4,937,332 shares of the company’s stock worth $274,022,000 after purchasing an additional 1,079,505 shares in the last quarter. Finally, Bessemer Group Inc. boosted its position in shares of Ryan Specialty by 33.9% during the 1st quarter. Bessemer Group Inc. now owns 1,925,864 shares of the company’s stock worth $106,886,000 after purchasing an additional 488,067 shares in the last quarter. 84.82% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Ryan Specialty

In other news, EVP Mark Stephen Katz sold 14,790 shares of the company’s stock in a transaction on Friday, November 8th. The shares were sold at an average price of $71.39, for a total value of $1,055,858.10. Following the transaction, the executive vice president now owns 12,386 shares of the company’s stock, valued at approximately $884,236.54. This represents a 54.42 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Nicholas Dominic Cortezi sold 35,000 shares of the company’s stock in a transaction on Monday, August 19th. The stock was sold at an average price of $64.69, for a total transaction of $2,264,150.00. Following the completion of the transaction, the director now directly owns 19,251 shares in the company, valued at approximately $1,245,347.19. The trade was a 64.51 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 94,193 shares of company stock valued at $6,208,493 in the last 90 days. 11.10% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on RYAN. The Goldman Sachs Group increased their price objective on shares of Ryan Specialty from $64.00 to $72.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 9th. UBS Group increased their price objective on shares of Ryan Specialty from $67.00 to $76.00 and gave the stock a “buy” rating in a research report on Tuesday, August 13th. BMO Capital Markets raised shares of Ryan Specialty from a “market perform” rating to an “outperform” rating and increased their price objective for the stock from $65.00 to $75.00 in a research report on Tuesday, September 24th. Barclays started coverage on shares of Ryan Specialty in a research report on Wednesday, September 4th. They issued an “overweight” rating and a $76.00 price target on the stock. Finally, Citigroup raised their price target on shares of Ryan Specialty from $56.00 to $62.00 and gave the company a “neutral” rating in a research report on Tuesday, July 23rd. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $70.33.

Ryan Specialty Trading Up 0.0 %

NYSE:RYAN opened at $70.94 on Friday. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. The stock has a market capitalization of $18.58 billion, a PE ratio of 92.13, a price-to-earnings-growth ratio of 1.63 and a beta of 0.62. The firm’s 50 day moving average is $68.28 and its 200 day moving average is $61.82. Ryan Specialty Holdings, Inc. has a 12 month low of $41.49 and a 12 month high of $73.10.

Ryan Specialty (NYSE:RYAN) last issued its earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.41. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. The business had revenue of $604.69 million for the quarter, compared to analysts’ expectations of $602.04 million. During the same quarter in the previous year, the firm posted $0.32 EPS. The business’s revenue for the quarter was up 20.5% compared to the same quarter last year. Sell-side analysts expect that Ryan Specialty Holdings, Inc. will post 1.8 earnings per share for the current year.

Ryan Specialty Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, November 26th. Shareholders of record on Tuesday, November 12th will be issued a dividend of $0.11 per share. The ex-dividend date is Tuesday, November 12th. This represents a $0.44 dividend on an annualized basis and a yield of 0.62%. Ryan Specialty’s payout ratio is 57.14%.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.